Search

everythinglearnresearchcommunity

for

Search:↓

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Choosing the right tools is crucial for accurately measuring lupus activity and damage.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

Hair loss in lupus patients indicates higher disease activity.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Hair loss in SLE patients is mostly due to chronic telogen effluvium and is linked to moderate disease activity.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Both patients and physicians are often dissatisfied with the control of systemic lupus erythematosus and lupus nephritis.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

Tph cells are linked to the severity of systemic lupus erythematosus.

Fungal infections can cause hair loss in lupus patients and should be considered even if rare.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Certain proteins involved in DNA modification may affect the genetic changes in systemic lupus erythematosus and could indicate the disease's activity.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

42% of SLE patients had thyroid issues, mostly hypothyroidism.

A girl with lupus and trisomy X has a higher risk of bone problems like avascular necrosis and osteoporosis.

Diagnosing new systemic lupus during pregnancy is hard but important for the health of the mother and baby.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

Certain skin symptoms can help detect and manage systemic lupus.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.